Integrated care pathways for airway diseases (AIRWAYS-ICPs)

European Respiratory Journal

Volumn 44, Issue 2, 2014, Pages 304-323

  Bousquet, J ^a,b,c,d,e,f   Addis, A ^d   Adcock, I ^g   Agache, I ^d,h,i   Agusti, A ^j   Alonso, A ^k   Annesi Maesano, I ^d   Anto, J M ^c,l   Bachert, C ^c,d,m   Baena Cagnani, C E ^d,n   Bai, C ^d,o   Baigenzhin, A ^p   Barbara, C ^d,q   Barnes, P J ^g   Bateman, E D ^d,r   Beck, L ^s   Bedbrook, A ^b,d   Bel, E H ^t   Benezet, O ^b   Bennoor, K S ^d,u   Benson, M ^v   Bernabeu Wittel, M ^d,w   Bewick, M ^x   Bindslev Jensen, C ^d,y   Blain, H ^a,b,f   Blasi, F ^z   Bonini, M ^d,aa   Bonini, S ^d,ab   Boulet, L P ^d,ac   Bourdin, A ^a,b,f,ad   Bourret, R ^a,b   Bousquet, P J ^d   Brightling, C E ^ae   Briggs, A ^af   Brozek, J ^d,ag   Buhl, R ^ah   Bush, A ^d,ai   Caimmi, D ^a,b,d   Calderon, M ^ai,aj   Calverley, P ^ak   Camargos, P A ^d,al   Camuzat, T ^b   Canonica, G W ^d,am   Carlsen, K H ^c,d,an,ao   Casale, T B ^d   Cazzola, M ^ap   Cepeda Sarabia, A M ^d,aq   Cesario, A ^ar   Chen, Y Z ^as   Chkhartishvili, E ^at   Chavannes, N H ^d,au,av   Chiron, R ^a,b,d   Chuchalin, A ^d,aw,ax   Chung, K F ^g   Cox, L ^d,ay   Crooks, G ^az   Crooks, M G ^ba   Cruz, A A ^d,aw,bb   Custovic, A ^d,e,bc   Dahl, R ^d,y   Dahlen, S E ^bd   De Blay, F ^d,be,bf   Dedeu, T ^bg   Deleanu, D ^d,h,bh   Demoly, P ^a,b,d,e,f   Devillier, P ^d,bi   Didier, A ^bj,bk   Dinh Xuan, A T ^bl   Djukanovic, R ^bm   Dokic, D ^d,bn   Douagui, H ^d,bo   Dubakiene, R ^d,bp,bq   Eglin, S ^ak   Elliot, F ^az   Emuzyte, R ^d,bp,bq   Fabbri, L ^br   Fink Wagner, A ^bs   Fletcher, M ^aw,bt   Fokkens, W J ^d,t,bu   Fonseca, J ^d,q,bv,bw   Franco, A ^bx   Frith, P ^by   Furber, A ^bz   Gaga, M ^ca   Garces J ^cb,cc   Garcia Aymerich, J ^c,l   Gamkrelidze, A ^d,cd   Gonzales Diaz, S ^d   Gouzi, F ^a,ad   Guzman M A ^d,ce   Haahtela, T ^c,d,cf   Harrison, D ^d   Hayot, M ^a,b,f   Heaney, L G ^cg   Heinrich, J ^c   Hellings, P W ^d,e,ch   Hooper, J ^d   Humbert, M ^bj   Hyland, M ^ci   Iaccarino, G ^d,cj,ck   Jakovenko, D ^b   Jardim, J R ^cl   Jeandel, C ^a,b,f   Jenkins, C ^cm   Johnston, S L ^d,g   Jonquet, O ^a,b,f   Joos, G ^m   Jung, K S ^cn   Kalayci, O ^d,e,co,cp   Karunanithi, S ^d   Keil, T ^c,cq,cr   Khaltaev, N ^d,aw   Kolek, V ^cs   Kowalski, M L ^ct   Kull, I ^c,bd   Kuna, P ^d,aw,cu   Kvedariene, V ^d,e,bp,bq   Le, L T ^d,aw,cv   Lodrup Carlsen, K C ^c,d,an,ao   Louis, R ^cw   MacNee, W ^cx   Mair, A ^cy   Majer, I ^cz   Manning, P ^da   De Manuel Keenoy, E ^d   Masjedi, M R ^db   Melen, E ^c,d,bd   Melo Gomes, E ^d,q   Menzies Gow, A ^ai   Mercier, G ^a,b,f   Mercier, J ^a,b,d,f   Michel, J P ^dc   Miculinic, N ^dd   Mihaltan, F ^d,h,de   Milenkovic, B ^df,dg,dh   Molimard, M ^di   Momas, I ^dj   Montilla Santana, A ^d   Morais Almeida, M ^dk,dl   Morgan, M ^x   N'Diaye, M ^dm   Nafti, S ^d,dn   Nekam, K ^d,do   Neou, A ^cq,dp   Nicod, L ^dq   O'Hehir, R ^d,dr   Ohta, K ^d,ds   Paggiaro, P ^dt   Palkonen, S ^c,d,du   Palmer, S ^dv   Papadopoulos, N G ^d,e,bc,dw   Papi, A ^dx   Passalacqua, G ^d,am   Pavord, I ^dy   Pigearias, B ^d   Plavec, D ^dz   Postma, D S ^c,ea   Price, D ^d,au,eb   Rabe, K F ^ec   Radier Ponta, F ^b   Redon, J ^d,cc   Rennard, S ^ed   Roberts, J ^ee   Robine, J M ^b,ef   Roca, J ^j   Roche, N ^bl   Rodenas, F ^cb,cc   Roggeri, A ^eg   Rolland, C ^eh   Rosado Pinto, J ^d,q,aw   Ryan, D ^d,au,ei,ej   Samolinski, B ^d,cu,ek   Sanchez Borges, M ^el   Schunemann H J ^ag   Sheikh, A ^ej,em   Shields, M ^en   Siafakas, N ^eo   Sibille, Y ^ep   Similowski, T ^eq,er,es,et   Small, I ^eu   Sola Morales, O ^ev   Sooronbaev, T ^d,aw,ew,ex   Stelmach, R ^ey   Sterk, P J ^t   Stiris, T ^ez,fa   Sud, P ^x   Tellier, V ^fb   To, T ^aw   Todo Bom, A ^fc   Triggiani, M ^cj   Valenta, R ^d,fd   Valero, A L ^j   Valiulis, A ^{d,bp,bq,fa,fe}   Valovirta, E ^ff   Van Ganse, E ^fg   Vandenplas, O ^d,er   Vasankari, T ^fh   Vestbo, J ^y,bc   Vezzani, G ^eg   Viegi, G ^fi,fu   Visier, L ^a,b,f   Vogelmeier, C ^fj   Vontetsianos, T ^fk   Wagstaff, R ^fl   Wahn, U ^cq   Wallaert, B ^be,fm   Whalley, B ^ci   Wickman, M ^c,d,bd   Williams, D M ^fn   Wilson, N ^d   Yawn, B P ^d,fo   Yiallouros, P K ^d,fp   Yorgancioglu, A ^d,co   Yusuf, O M ^aw,fq   Zar, H J ^fr   Zhong, N ^fs   Zidarn, M ^d,ft   Zuberbier, T ^cq,dp   more..

^a MONTPELLIER UNIVERSITY HOSPITAL   (France)

^b MACVIA LR   (France)

^c MeDALL Mechanisms of the Development of Allergy   (France)

^d ARIA Allergic Rhinitis and Its Impact on Asthma ^*  (United Kingdom)

^e Allergol Section and Board of UEMS   (Italy)

^f UNIV MONTPELLIER   (France)

^g NATIONAL HEART AND LUNG INSTITUTE   (United Kingdom)

^h Romanian Alliance Against Chronic Respiratory Diseases   (Romania)

ⁱ TRANSILVANIA UNIVERSITY OF BRASOV   (Romania)

^j UNIVERSITY OF BARCELONA   (Spain)

^k HOSPITAL CLÍNIC   (Spain)

^l UNIVERSITAT POMPEU FABRA   (Spain)

^m GHENT UNIVERSITY HOSPITAL   (Belgium)

ⁿ UNIVERSIDAD CATÓLICA DE CÓRDOBA   (Argentina)

^o Shanghai Branch   (China)

^p EuroAsian Respiratory Society   (Kazakhstan)

^q PNDR Portuguese National Programme for Respiratory Diseases   (Portugal)

^r UNIVERSITY OF CAPE TOWN   (South Africa)

^s Health Innovation Centre of Southern Denmark   (Denmark)

^t UNIVERSITY OF AMSTERDAM   (Netherlands)

^u National Institute of Diseases of Chest and Hospital   (Bangladesh)

^v LINKÖPING UNIVERSITY   (Sweden)

^w Andalusian Health Care Service   (Spain)

^x NATIONAL HEALTH SERVICE   (United Kingdom)

^y ODENSE UNIVERSITY HOSPITAL   (Denmark)

^z UNIVERSITY OF MILAN   (Italy)

^aa SAPIENZA UNIVERSITY OF ROME   (Italy)

^ab SECOND UNIVERSITY OF NAPLES   (Italy)

^ac LAVAL UNIVERSITY   (Canada)

^ad UNIVERSITY OF MONTPELLIER   (France)

^ae Dept of Dermatology and Allergy Center Odense Research Center for Anaphylaxis Odense University Hospital ^*  (United Kingdom)

^af UNIVERSITY OF GLASGOW   (United Kingdom)

^ag MCMASTER UNIVERSITY   (Canada)

^ah UNIVERSITY MEDICAL CENTER MAINZ   (Germany)

^ai ROYAL BROMPTON HOSPITAL   (United Kingdom)

^aj UNIVERSIDAD DE COSTA RICA   (Costa Rica)

^ak UNIVERSITY OF LIVERPOOL   (United Kingdom)

^al FEDERAL UNIVERSITY OF MINAS GERAIS   (Brazil)

^am UNIVERSITY OF GENOA   (Italy)

^an NAH National Allergy Health Programme   (Norway)

^ao UNIVERSITY OF OSLO   (Norway)

^ap UNIVERSITY OF ROME TOR VERGATA   (Italy)

^aq UNIVERSIDAD SIMÓN BOLÍVAR   (Colombia)

^ar IRCCS SAN RAFFAELE PISANA   (Italy)

^as CAPITAL INSTITUTE OF PEDIATRICS   (China)

^at Georgia   (Georgia)

^au IPCRG International Primary Care Respiratory Group   (Netherlands)

^av LEIDEN UNIVERSITY MEDICAL CENTER   (Netherlands)

^aw GARD Global Alliance Against Chronic Respiratory Diseases (WHO)   (Netherlands)

^ax Pulmonology Research Institute   (Russian Federation)

^ay NOVA SOUTHEASTERN UNIVERSITY   (United States)

^az HEALTHCARE IMPROVEMENT SCOTLAND   (United Kingdom)

^ba UNIVERSITY OF HULL   (United Kingdom)

^bb FEDERAL UNIVERSITY OF BAHIA   (Brazil)

^bc UNIVERSITY OF MANCHESTER   (United Kingdom)

^bd KAROLINSKA INSTITUTE   (Sweden)

^be SFA   (France)

^bf UNIVERSITÉ DE STRASBOURG   (France)

^bg EUREGHA European Regions and Health Authorities   (Belgium)

^bh IULIU HATIEGANU UNIVERSITY OF MEDICINE AND PHARMACY   (Romania)

^bi LABORATOIRE DES SCIENCES DU CLIMAT ET DE L ENVIRONNEMENT   (France)

^bj Société de pneumologie de langue française SPLF   (France)

^bk UNIVERSITÉ DE TOULOUSE   (France)

^bl Centre for Allergy Research Institute of Environmental Medicine Karolinska Institutet ^*  (France)

^bm UNIVERSITY OF SOUTHAMPTON   (United Kingdom)

^bn SS CYRIL AND METHODIUS UNIVERSITY   (Macedonia)

^bo Centre Hospitalier et Universitaire de Beni Messous Algiers   (Algeria)

^bp LSACI Lithuanian Society of Allergology and Clinical Immunology   (Lithuania)

^bq VILNIUS UNIVERSITY   (Lithuania)

^br UNIVERSITY OF MODENA AND REGGIO EMILIA   (Italy)

^bs GAAPP Global Allergy and Asthma Patient Platform   (Austria)

^bt EDUCATION FOR HEALTH   (United Kingdom)

^bu European Rhinologic Society   (Italy)

^bv Porto Age Up Consortium   (Portugal)

^bw UNIVERSITY OF PORTO   (Portugal)

^bx UNIVERSITÉ CÔTE D'AZUR   (France)

^by REPATRIATION GENERAL HOSPITAL   (Australia)

^bz Wakefield Council   (United Kingdom)

^ca Athens Chest Hospital   (Greece)

^cb EIP on AHA European Innovation Partnership on Active and Healthy Ageing Reference Site   (Spain)

^cc UNIVERSITY OF VALENCIA   (Spain)

^cd National Centre for Disease Control and Public Health of Georgia   (Georgia)

^ce HOSPITAL CLÍNICO UNIVERSIDAD DE CHILE   (Chile)

^cf HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

^cg QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^ch UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^ci UNIVERSITY OF PLYMOUTH   (United Kingdom)

^cj UNIVERSITY OF SALERNO   (Italy)

^ck IRCCS MULTIMEDICA   (Italy)

^cl FEDERAL UNIVERSITY OF SÃO PAULO   (Brazil)

^cm UNIVERSITY OF SYDNEY   (Australia)

^cn Hallym University Sacred Heart Hospital   (South Korea)

^co GARD Turkey Global Alliance Against Chronic Respiratory Diseases (GARD)   (Turkey)

^cp HACETTEPE UNIVERSITY   (Turkey)

^cq CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^cr UNIVERSITY OF WÜRZBURG   (Germany)

^cs CARO Czech Alliance Against Chronic Respiratory Diseases   (Czech Republic)

^ct MEDICAL UNIVERSITY OF LODZ   (Poland)

^cu N Barlicki University Hospital No 1 of Medical University of Lodz   (Poland)

^cv UNIVERSITY OF MEDICINE AND PHARMACY AT HO CHI MINH CITY   (Viet Nam)

^cw UNIVERSITY OF LIÈGE   (Belgium)

^cx UNIVERSITY OF EDINBURGH   (United Kingdom)

^cy SCOTTISH GOVERNMENT   (United Kingdom)

^cz Physics and Informatics   (Slovakia)

^da ROYAL COLLEGE OF SURGEONS IN IRELAND   (Ireland)

^db SHAHID BEHESHTI UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^dc GENEVA UNIVERSITY HOSPITALS   (Switzerland)

^dd University Hospital for Lung Diseases Jordanovac   (Croatia)

^de Marius Nasta Institute   (Romania)

^df UNIVERSITY OF BELGRADE   (Serbia)

^dg Serbian Alliance Against Chronic Respiratory Diseases   (Serbia)

^dh Association for Asthma and COPD   (Serbia)

^di UNIVERSITÉ DE BORDEAUX   (France)

^dj AP HP   (France)

^dk Hospital CUF Descobertas   (Portugal)

^dl Directorate of Finance eHealth and Pharmaceuticals Scottish Government Health Dept ^*  (Portugal)

^dm IHS Dakar Hospital   (Senegal)

^dn CHU Mustapha   (Algeria)

^do Hospital of the Hospitaller Brothers in Buda   (Hungary)

^dp GA2LEN Global Allergy and Asthma European Network   (Italy)

^dq LAUSANNE UNIVERSITY HOSPITAL   (Switzerland)

^dr ALFRED HOSPITAL   (Australia)

^ds TOKYO NATIONAL HOSPITAL   (Japan)

^dt UNIVERSITY HOSPITAL OF PISA   (Italy)

^du EFA European Federation of Allergy and Airways Diseases Patients' Association   (Italy)

^dv UNIVERSITY OF YORK   (United Kingdom)

^dw UNIVERSITY OF ATHENS   (Greece)

^dx UNIVERSITY OF FERRARA   (Italy)

^dy UNIVERSITY OF OXFORD   (United Kingdom)

^dz JOSIP JURAJ STROSSMAYER UNIVERSITY OF OSIJEK   (Croatia)

^ea UNIVERSITY MEDICAL CENTER GRONINGEN   (Netherlands)

^eb UNIVERSITY OF ABERDEEN   (United Kingdom)

^ec UNIVERSITY OF KIEL   (Germany)

^ed NEBRASKA MEDICAL CENTER   (United States)

^ee SALFORD ROYAL NHS FOUNDATION TRUST   (United Kingdom)

^ef University of Montpellier   (France)

^eg S MARIA NUOVA HOSPITAL   (Italy)

^eh Association asthme et allergies   (France)

^ei Woodbrook Medical Centre   (United Kingdom)

^ej UNIVERSITY OF EDINBURGH   (United Kingdom)

^ek MEDICAL UNIVERSITY OF WARSAW   (Poland)

^el Centro Medico Docente La Trinidad   (Venezuela)

^em BRIGHAM AND WOMEN S HOSPITAL   (United States)

^en QUEEN'S UNIVERSITY BELFAST   (United Kingdom)

^eo UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^ep UNIVERSITY HOSPITAL OF MONT GODINNE   (Belgium)

^eq SORBONNE UNIVERSITÉ   (France)

^er INSERM   (France)

^es PITIÉ SALPÊTRIÈRE HOSPITAL   (France)

^et Fonds de Dotation Recherche en Santé Respiratoire Fondation du Souffle   (France)

^eu National Advisory Group Respiratory Managed Clinical Networks in Scotland   (United Kingdom)

^ev HITT Health Institute for Technology Transfer   (Spain)

^ew EuroAsian Respiratory Society   (Kyrgyzstan)

^ex Laboratory of Human Genetics   (Kyrgyzstan)

^ey UNIVERSITY OF SÃO PAULO   (Brazil)

^ez OSLO UNIVERSITY HOSPITAL   (Norway)

^fa European Academy of Paediatrics (EAP UEMS)   (Italy)

^fb Observatoire Wallon de la Santé Direction Generale Operationnelle Pouvoirs Locaux Action Sociale et Sante Service Public de Wallonie   (Belgium)

^fc CENTRO HOSPITALAR E UNIVERSITÁRIO DE COIMBRA   (Portugal)

^fd MEDICAL UNIVERSITY OF VIENNA   (Austria)

^fe Lithuanian National Alliance Against Chronic Respiratory Diseases   (Lithuania)

^ff UNIVERSITY OF TURKU   (Finland)

^fg UNIVERSITÉ LYON 1   (France)

^fh FILHA Finnish Lung Association   (United Kingdom)

^fi CNR Consiglio Nazionale delle Ricerche   (Italy)

^fj UNIVERSITY HOSPITAL GIESSEN   (Germany)

^fk SOTIRIA GENERAL HOSPITAL   (Greece)

^fl CUMBRIA COUNTY COUNCIL   (United Kingdom)

^fm LILLE UNIVERSITY HOSPITAL   (France)

^fn University of North Carolina   (United States)

^fo UNIVERSITY OF MINNESOTA   (United States)

^fp CYPRUS UNIVERSITY OF TECHNOLOGY   (Cyprus)

^fq Allergy and Asthma Institute   (Pakistan)

^fr UNIVERSITY OF CAPE TOWN   (South Africa)

^fs GUANGZHOU MEDICAL UNIVERSITY   (China)

^ft UNIVERSITY CLINIC OF RESPIRATORY AND ALLERGIC DISEASES   (Slovenia)

^fu INSTITUTE OF CLINICAL PHYSIOLOGY   (Italy)

more..

Author keywords

[No Author keywords available]

Indexed keywords

BETA 2 ADRENERGIC RECEPTOR STIMULATING AGENT; CORTICOSTEROID;

ASTHMA; CHILD HEALTH CARE; CHRONIC OBSTRUCTIVE LUNG DISEASE; CHRONIC RESPIRATORY TRACT DISEASE; COMORBIDITY; CONCEPTUAL FRAMEWORK; COST EFFECTIVENESS ANALYSIS; DIAGNOSTIC TEST; DISABILITY; DISEASE CONTROL; EARLY DIAGNOSIS; EARLY INTERVENTION; EDUCATION PROGRAM; ELDERLY CARE; EMERGENCY CARE; ENVIRONMENTAL EXPOSURE; EUROPE; EUROPEAN UNION; HEALTH CARE COST; HEALTH CARE POLICY; HEALTH PROGRAM; HEALTH PROMOTION; HOSPITALIZATION; HUMAN; INCIDENCE; INTEGRATED HEALTH CARE SYSTEM; KNOWLEDGE; LIFE CYCLE; LONG TERM CARE; MEDICAL CARE; MORBIDITY; PATIENT CARE; PATIENT CODING; PRACTICE GUIDELINE; PREVENTIVE HEALTH SERVICE; PRIORITY JOURNAL; PROGRAM DEVELOPMENT; PUBLIC HEALTH SERVICE; QUALITY OF LIFE; REVIEW; RISK FACTOR; SIMULATION; SMOKING; SOCIAL CARE; AGING; DECISION MAKING; HEALTH CARE PLANNING; INTERNATIONAL COOPERATION; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; RESPIRATION DISORDERS; RHINITIS; WORLD HEALTH ORGANIZATION;

AGING; ASTHMA; DECISION MAKING; EUROPE; EUROPEAN UNION; GUIDELINES AS TOPIC; HUMANS; INTERNATIONAL COOPERATION; MEDICALLY UNDERSERVED AREA; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; QUALITY OF LIFE; RESPIRATION DISORDERS; RHINITIS; RISK FACTORS; WORLD HEALTH ORGANIZATION;

EID: 84905650943     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00014614     Document Type: Review

References (69)

1. Bousquet J, Khaltaev N. Global Surveillance, Prevention and Control of Chronic Respiratory Diseases. A Comprehensive Approach. Global Alliance against Chronic Respiratory Diseases. Geneva, World Health Organization Press, 2007.
2. Gibson GJ, Loddenkemper R, Sibille, et al., eds. European Lung White Book. 2nd Edn. Sheffield, European Respiratory Society, 2013.
3. Svanes C, Sunyer J, Plana E, et al. Early life origins of chronic obstructive pulmonary disease. Thorax 2010; 65: 14-20.
4. Perret JL, Dharmage SC, Matheson MC, et al. The interplay between the effects of lifetime asthma, smoking, and atopy on fixed airflow obstruction in middle age. Am J Respir Crit Care Med 2013; 187: 42-48.
5. Qaseem A, Wilt TJ, Weinberger SE, et al. Diagnosis and management of stable chronic obstructive pulmonary disease: a clinical practice guideline update from the American College of Physicians, American College of Chest Physicians, American Thoracic Society, and European Respiratory Society. Ann Intern Med 2011; 155: 179-191.
6. Brozek JL, Bousquet J, Baena-Cagnani CE, et al. Allergic Rhinitis and its Impact on Asthma (ARIA) guidelines: 2010 revision. J Allergy Clin Immunol 2010; 126: 466-476.
7. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ 2008; 336: 924-926. (Pubitemid 351632017)
8. Brozek JL, Akl EA, Compalati E, et al. Grading quality of evidence and strength of recommendations in clinical practice guidelines part 3 of 3. The GRADE approach to developing recommendations. Allergy 2011; 66: 588-595.
9. Bateman ED, Hurd SS, Barnes PJ, et al. Global strategy for asthma management and prevention: GINA executive summary. Eur Respir J 2008; 31: 143-178.
10. Vestbo J, Hurd SS, Agusti AG, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Pulmonary Disease: GOLD Executive Summary. Am J Respir Crit Care Med 2013; 187: 347-365.
11. Gibson PG, Simpson JL. The overlap syndrome of asthma and COPD: what are its features and how important is it? Thorax 2009; 64: 728-735.
12. Pistelli R, Ferrara L, Misuraca C, et al. Practical management problems of stable chronic obstructive pulmonary disease in the elderly. Curr Opin Pulm Med 2011; 17: Suppl. 1, S43-S48.
13. Haahtela T, Tuomisto LE, Pietinalho A, et al. A 10 year asthma programme in Finland: major change for the better. Thorax 2006; 61: 663-670. (Pubitemid 44211772)
14. Kinnula VL, Vasankari T, Kontula E, et al. The 10-year COPD Programme in Finland: effects on quality of diagnosis, smoking, prevalence, hospital admissions and mortality. Prim Care Respir J 2011; 20: 178-183.
15. Souza-Machado C, Souza-Machado A, Franco R, et al. Rapid reduction in hospitalisations after an intervention to manage severe asthma. Eur Respir J 2010; 35: 515-521.
16. National Clinical Guideline Centre for Acute and Chronic Conditions. Chronic Obstructive Pulmonary Disease: Management of Chronic Obstructive Pulmonary Disease in Adults in Primary and Secondary Care (partial update). London, National Clinical Guideline Centre for Acute and Chronic Conditions, 2010. Available from: http://guidance.nice.org.uk/CG101
17. Long Alliantie Nederland. Zorgstandaard astma Volwassenen [Standards of Care for Asthma in Adults]. Amersfoort, Long Alliantie Nederland, 2012. Available from: www.longalliantie.nl/files/6113/6752/1347/Zorgstandaard-Astma- Volwassenen.pdf
18. Long Alliantie Nederland. Zorgstandaard astma Kinderen & Jongeren [Standards of Care for Asthma in Children and Young People]. Amersfoort, Long Alliantie Nederland, 2012. Available from: www.longalliantie.nl/files/6513/6752/ 1347/Zorgstandaard-Astma-Kinderen-en-Jongeren.pdf
19. Long Alliantie Nederland. Zorgstandaard COPD [Standards of Care for COPD]. Amersfoort, Long Alliantie Nederland, 2013. Available from: www.longalliantie.nl/files/5113/7994/2952/LAN-Zorgstandaard-COPD-2013-juni.pdf
20. National Institute for Health and Clinical Excellence. Asthma. Quality standards. http://publications.nice.org.uk/quality-standard-for-asthma-qs25 February 2013. Date last accessed: January 12, 2014.
21. QOF Clinical Indicators 2013/14: Summary Tables. www.eguidelines.co.uk/ eguidelinesmain/external-guidelines/qof.php April 2013. Date last accessed: January 12, 2014.
22. World Health Organization. Package of Essential NCD Interventions for Primary Health Care: Cancer, Diabetes, Heart Disease and Stroke, Chronic Respiratory Disease. Geneva, WHO Press, 2010.
23. Hamzaoui A, Ottmani S. Practical approach to lung health: lung health for everyone? Eur Respir Rev 2012; 21: 186-195.
24. English RG, Bateman ED, Zwarenstein MF, et al. Development of a South African integrated syndromic respiratory disease guideline for primary care. Prim Care Respir J 2008; 17: 156-163.
25. Samolinski B, Fronczak A, Wlodarczyk A, et al. Council of the European Union conclusions on chronic respiratory diseases in children. Lancet 2012; 379: e45-e46.
26. Samolinski B, Fronczak A, Kuna P, et al. Prevention and control of childhood asthma and allergy in the EU from the public health point of view: Polish Presidency of the European Union. Allergy 2012; 67: 726-731.
27. Council Conclusions on Healthy Ageing Across the Lifecycle. 3206th Employment, Social Policy, Health and Consumer Affairs Council Meeting. Brussels, 7 December 2012. http://www.consilium.europa.eu/uedocs/cms-data/docs/ pressdata/en/lsa/134097pdf December 2012. Date last accessed: January 12, 2014.
28. Bousquet J, Tanasescu C, Camuzat T, et al. Impact of early diagnosis and control of chronic respiratory diseases on active and healthy ageing. A debate at the European Union Parliament. Allergy 2013; 68: 555-561.
29. Bousquet J, Anto JM, Sterk PJ, et al. Systems medicine and integrated care to combat chronic noncommunicable diseases. Genome Med 2011; 3: 43.
30. Yanbaeva DG, Dentener MA, Creutzberg EC, et al. Systemic effects of smoking. Chest 2007; 131: 1557-1566. (Pubitemid 46762366)
31. Petersen AM, Pedersen BK. The anti-inflammatory effect of exercise. J Appl Physiol 2005; 98: 1154-1162. (Pubitemid 40396484)
32. European Union/Innovation Union. Consultation on the Pilot European Innovation Partnership on Active and Healthy Ageing. http://ec.europa.eu/ research/innovation-union/index-en.cfm?section5active-healthy-ageing January 2014. Date last accessed: January 12, 2014.
33. Campbell H, Hotchkiss R, Bradshaw N, et al. Integrated care pathways. BMJ 1998; 316: 133-137. (Pubitemid 28121114)
34. Overill S. A practical guide to care pathways. J Integr Care 1998; 2: 93-98. (Pubitemid 29010524)
35. Great Ormond Street Hospital for Children NHS Trust. How to Produce and Evaluate an Integrated Care Pathway (ICP): Information for Staff. London, Great Ormond Street Hospital for Children NHS Trust, 2010. Available from: www.gosh.nhs.uk/health-professionals/integrated-care-pathways/
36. Integrated Care Pathways Users in Scotland (ICPUS). A Workbook for People Starting to Develop Integrated Care Pathways. ICPUS, 2007. Available from: www.icpus.org.uk/wp-content/uploads/2007/08/icpus-workbook-2007.pdf
37. Campbell SM, Reeves D, Kontopantelis E, et al. Effects of pay for performance on the quality of primary care in England. N Engl J Med 2009; 361: 368-378.
38. Kirschner K, Braspenning J, Akkermans RP, et al. Assessment of a pay-for-performance program in primary care designed by target users. Fam Pract 2013; 30: 161-171.
39. Rodriguez HP, Perry L, Conrad DA, et al. The reliability of medical group performance measurement in a single insurer's pay for performance program. Med Care 2012; 50: 117-123.
40. Pinnock H, Burton C, Campbell S, et al. Clinical implications of the Royal College of Physicians three questions in routine asthma care: a real-life validation study. Prim Care Respir J 2012; 21: 288-294.
41. Ouwens M, Hulscher M, Hermens R, et al. Implementation of integrated care for patients with cancer: a systematic review of interventions and effects. Int J Qual Health Care 2009; 21: 137-144.
42. Chan R, Webster J. End-of-life care pathways for improving outcomes in caring for the dying. Cochrane Database Syst Rev 2010; CD008006.
43. Doods S. Designing improved health care processes using discrete event stimulation. Br J Healthcare Comput Inf Manag 2005; 22: 14-16.
44. O'Connor J, Seeto C, Saini B, et al. Healthcare professional versus patient goal setting in intermittent allergic rhinitis. Patient Educ Couns 2008; 70: 111-117. (Pubitemid 350256923)
45. Lisspers K, Odeback P. Riktlinjer for allergisk rinit och astma maste na ut. Primarvarden och de lokala apoteken behover samarbeta mer [Guidelines for allergic rhinitis and asthma must reach out. Primary health care and the local pharmacies need to cooperate more]. Lakartidningen 2012; 109: 615.
46. Sullivan PW, Nair KV, Patel BV. The effect of the Rx-to-OTC switch of loratadine and changes in prescription drug benefits on utilization and cost of therapy. Am J Manag Care 2005; 11: 374-382. (Pubitemid 40875306)
47. European Innovation Partnership on Active and Healthy Ageing. The Specific Actions and How to Engage in their Implementation. http://ec.europa.eu/ research/innovation-union/index-en.cfm?section5active-healthy-ageing March 6, 2012. Date last accessed: January 12, 2014.
48. World Health Organization Regional Office for Europe. Strategy and Action Plan for Healthy Ageing in Europe, 2012-2020. Copenhagen, World Health Organization Regional Office for Europe, 2012. Available from: www.euro.who.int/--data/assets/pdf-file/0008/175544/RC62wd10Rev1-Eng.pdf
49. Bousquet J, Mantzouranis E, Cruz AA, et al. Uniform definition of asthma severity, control, and exacerbations: document presented for the World Health Organization Consultation on Severe Asthma. J Allergy Clin Immunol 2010; 126: 926-938.
50. Bousquet J, Anto JM, Demoly P, et al. Severe chronic allergic (and related) diseases: a uniform approach - a MeDALL-GA2LEN-ARIA position paper. Int Arch Allergy Immunol 2012; 158: 216-231.
51. Haahtela T, von Hertzen L, Makela M, et al. Finnish Allergy Programme 2008-2018 - time to act and change the course. Allergy 2008; 63: 634-645. (Pubitemid 351591861)
52. International Primary Care Respiratory Group. Mapping of National Guidelines used by Primary Care. www.theipcrg.org/display/ResMapping/ Mapping+of+national+guidelines+used+by+primary+care July 2013. Date last accessed: January 12, 2014.
53. Council of the European Union. Council Conclusions: Innovative Approaches for Chronic Diseases in Public Health and Healthcare Systems. 3053rd Employment, Social Policy Health and Consumer Affairs Council Meeting, Brussels, 7 December 2010. www.consilium.europa.eu/uedocs/cms-data/docs/pressdata/en/lsa/ 118282.pdf December 2010. Date last accessed: January 12, 2014.
54. Bousquet J, Clark TJ, Hurd S, et al. GINA guidelines on asthma and beyond. Allergy 2007; 62: 102-112. (Pubitemid 46091634)
55. Bel EH, Sousa A, Fleming L, et al. Diagnosis and definition of severe refractory asthma: an international consensus statement from the Innovative Medicine Initiative (IMI). Thorax 2011; 66: 910-917.
56. National Heart, Lung and Blood Institute. National Asthma Education and Prevention Program. Expert Panel Report 3: Guidelines for the Diagnosis and Management of Asthma. Bethesda, US Department of Health and Human Services, 2007.
57. Hamrock E, Paige K, Parks J, et al. Discrete event simulation for healthcare organizations: a tool for decision making. J Healthc Manag 2013; 58: 110-124.
58. Bolton P, Power P. Better than a crystal ball? Using simulation to foresee emerging issues in the Australian Healthcare System. World Hosp Health Serv 2011; 47: 31-33.
59. Lee BY, Wong KF, Bartsch SM, et al. The Regional Healthcare Ecosystem Analyst (RHEA): a simulation modeling tool to assist infectious disease control in a health system. J Am Med Inform Assoc 2013; 20: e139-e146.
60. Murray RE, Ryan PB, Reisinger SJ. Design and validation of a data simulation model for longitudinal healthcare data. AMIA Annu Symp Proc 2011; 1176-1185.
61. Borycki EM, Kushniruk A, Keay E, et al. Toward an integrated simulation approach for predicting and preventing technology-induced errors in healthcare: implications for healthcare decision-makers. Healthc Q 2009; 12: 90-96.
62. Pidaparti RM, Koombua K. Simulation of the effect of airway disease on respiratory airways. J Med Eng Technol 2012; 36: 338-343.
63. Grimaldo F, Orduña JM, Lozano M, et al. Towards a simulator of integrated long-term care systems for elderly people. Int J Artificial Intelligence Tools 2014; 23: 1440005.
64. Barker DJ, Bull AR, Osmond C, et al. Fetal and placental size and risk of hypertension in adult life. BMJ 1990; 301: 259-262. (Pubitemid 20241224)
65. Krauss-Etschmann S, Bush A, Bellusci S, et al. Of flies, mice and men: a systematic approach to understanding the early life origins of chronic lung disease. Thorax 2013; 68: 380-384.
66. Simeoni U, Barker DJ. Offspring of diabetic pregnancy: long-term outcomes. Sem Fetal NeonatMed 2009; 14: 119-124.
67. Barker DJ. Coronary heart disease: a disorder of growth. Horm Res 2003; 59: Suppl. 1, 35-41. (Pubitemid 36173408)
68. Bousquet J, Jacot W, Yssel H, et al. Epigenetic inheritance of fetal genes in allergic asthma. Allergy 2004; 59: 138-147. (Pubitemid 38250767)
69. Landrigan PJ, Sonawane B, Butler RN, et al. Early environmental origins of neurodegenerative disease in later life. Environ health Perspect 2005; 113: 1230-1233. (Pubitemid 41387665)